Literature DB >> 7732989

Chaotic atrial rhythm in children.

H Dodo1, R M Gow, R M Hamilton, R M Freedom.   

Abstract

Chaotic atrial rhythm (CAR) usually occurs as a sequela of chronic obstructive lung disease in adults. We report the clinical manifestations and response to therapy in nine children with CAR treated predominantly with propafenone or amiodarone. Age at presentation ranged from 1 day to 30 months; six patients were < or = 2 weeks old. Six patients had tachycardia, and three had congestive heart failure. The atrial rate was 200 to 500 (mean 369 +/- 71) beats/min and the ventricular rate 150 to 300 (mean 251 +/- 37) beats/min. Eight patients had cardiac abnormalities. Intravenous drug therapy was not successful in converting CAR to sinus rhythm in any patient. A mean of four (range three to five) drugs was used in each patient; amiodarone and propafenone, alone or in combination, proved most successful. Seven patients were discharged from the hospital: full control was achieved in three (digoxin and amiodarone in two and digoxin, amiodarone, and procainamide in one), good control in three (digoxin, amiodarone, and propafenone in two and digoxin and propafenone in one), and ventricular rate control in one (digoxin, amiodarone, and propafenone). Two neonates with hypertrophic cardiomyopathy died. Long-term follow-up showed that CAR had resolved in five patients but persisted in two. We conclude that CAR remains difficult to control despite the use of newer antiarrhythmic agents but may resolve during long-term follow-up.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732989     DOI: 10.1016/0002-8703(95)90121-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.

Authors:  Mark D Levin; Sulagna C Saitta; Karen W Gripp; Tara L Wenger; Jaya Ganesh; Jennifer M Kalish; Michael R Epstein; Rosemarie Smith; Richard J Czosek; Stephanie M Ware; Paula Goldenberg; Angela Myers; Kathryn C Chatfield; Matthew J Gillespie; Elaine H Zackai; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-07-28       Impact factor: 2.802

Review 4.  Perinatal arrhythmias: diagnosis and management.

Authors:  Janette F Strasburger; Bageshree Cheulkar; Heather J Wichman
Journal:  Clin Perinatol       Date:  2007-12       Impact factor: 3.430

5.  The Complexity of Pediatric Multifocal Atrial Tachycardia and Its Prognostic Factors.

Authors:  Seung Min Baek; Hyun Chung; Mi Kyoung Song; Eun Jung Bae; Gi Beom Kim; Chung Il Noh
Journal:  Korean Circ J       Date:  2018-02       Impact factor: 3.243

6.  [Atrial chaotic tachycardia during a respiratory tract infection due to NL63 coronavirus].

Authors:  J Chantreuil; G Favrais; N Soule; Z Maakaroun-Vermesse; A Chaillon; A Chantepie; E Saliba
Journal:  Arch Pediatr       Date:  2013-02-05       Impact factor: 1.180

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.